E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/2/2012 in the Prospect News PIPE Daily.

Encision takes in $1.5 million through private placement of its shares

Company sells 1.5 million shares at $1.00 per share, a 13.04% discount

By Devika Patel

Knoxville, Tenn., April 2 - Encision Inc. said it completed a $1.5 million private placement of stock.

The company sold 1.5 million common shares at $1.00 per share. The price per share reflects a 13.04% discount to $1.15, the closing share price on March 30 and is also about a 6% discount to the 20-day volume-weighted average price on March 30, the company said in a press release.

"Net proceeds from the sale of the shares will be used for sales, marketing and quality programs and needed product development to enable the company to aggressively execute its business plan," president and chief executive officer Fred Perner said in a press release.

"In addition, this common stock private placement, together with our line of credit with Silicon Valley Bank, has greatly improved the company's liquidity position."

Encision is a medical device company located in Boulder, Colo.

Issuer:Encision Inc.
Issue:Common stock
Amount:$1.5 million
Shares:1.5 million
Price:$1.00
Warrants:No
Settlement date:April 2
Stock symbol:Pink Sheets: ECIA
Stock price:$1.15 at close March 30
Market capitalization:$6.78 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.